253 related articles for article (PubMed ID: 24107468)
21. Identification of a circulating microRNA signature for colorectal cancer detection.
Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
[TBL] [Abstract][Full Text] [Related]
22. Circulating midkine in malignant and non-malignant colorectal diseases.
Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
[TBL] [Abstract][Full Text] [Related]
23. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
[TBL] [Abstract][Full Text] [Related]
24. Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
Kemper M; Hentschel W; Graß JK; Stüben BO; Konczalla L; Rawnaq T; Ghadban T; Izbicki JR; Reeh M
Cancer Med; 2020 Mar; 9(6):2010-2018. PubMed ID: 31984657
[TBL] [Abstract][Full Text] [Related]
25. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
26. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.
Taguchi A; Rho JH; Yan Q; Zhang Y; Zhao Y; Xu H; Tripathi SC; Wang H; Brenner DE; Kucherlapati M; Kucherlapati R; Boutin AT; Wang YA; DePinho RA; Feng Z; Lampe PD; Hanash SM
Cancer Prev Res (Phila); 2015 Nov; 8(11):1112-9. PubMed ID: 26342024
[TBL] [Abstract][Full Text] [Related]
27. Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy.
Piper TB; Nielsen HJ; Christensen IJ
Tumour Biol; 2022; 44(1):1-16. PubMed ID: 35180141
[TBL] [Abstract][Full Text] [Related]
28. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers.
Liu H; Ye D; Chen A; Tan D; Zhang W; Jiang W; Wang M; Zhang X
Clin Chem Lab Med; 2019 Jun; 57(7):1073-1083. PubMed ID: 30978169
[TBL] [Abstract][Full Text] [Related]
29. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
30. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
31. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
32. Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP
Uchiyama K; Naito Y; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Handa O; Ishikawa T; Takagi T; Konishi H; Nonaka D; Asada K; Lee LJ; Tanaka K; Kuriu Y; Nakanishi M; Otsuji E; Itoh Y
J Gastroenterol; 2018 Nov; 53(11):1179-1185. PubMed ID: 29497816
[TBL] [Abstract][Full Text] [Related]
33. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ
Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152
[TBL] [Abstract][Full Text] [Related]
34. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.
Nielsen HJ; Brünner N; Jorgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Stieber P; Blankenstein MA; Davis G; Dowell BL; Christensen IJ; ;
Scand J Gastroenterol; 2011 Jan; 46(1):60-9. PubMed ID: 20799911
[TBL] [Abstract][Full Text] [Related]
35. Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer.
Dai C; Zhang X; Ma Y; Chen Z; Chen S; Zhang Y; Li M
Biomarkers; 2021 Nov; 26(7):598-605. PubMed ID: 34266319
[TBL] [Abstract][Full Text] [Related]
36. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage.
Kasanga M; Liu L; Xue L; Song X
Biomark Med; 2018 Aug; 12(8):881-890. PubMed ID: 29939072
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
[TBL] [Abstract][Full Text] [Related]
39. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker.
Crotti S; Agnoletto E; Cancemi G; Di Marco V; Traldi P; Pucciarelli S; Nitti D; Agostini M
Anal Bioanal Chem; 2016 Sep; 408(23):6321-8. PubMed ID: 27379390
[TBL] [Abstract][Full Text] [Related]
40. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]